Ajax-Loading

Company Selected - Chugai Pharmaceutical Co. Ltd. - Income Statement















Ajax-Loading
Fiscal Year is From January To December - All Figures are in , Thousands, Except for the Diluted EPS Figure06/30/202503/31/202512/31/202409/30/2024View Chart

Total Revenue

1,196,215,0001,222,121,0001,170,611,0001,142,350,000

[-] Cost of Goods Sold (COGS) incl. D&A

354,410,000354,282,000339,409,000337,168,000

Hid COGS excluding D&A

354,410,000354,282,000339,409,000337,168,000

Hid Depreciation & Amortization Expense

0.00.00.00.0

Gross Profit

841,805,000867,839,000831,202,000805,182,000

[-] Operating Expenses

278,884,000285,462,000286,147,000268,916,000

Hid Selling General Administrative (SG&A)

- 29,315,000.0053,305,000.0089,264,000.00

Hid Research & Development

183,739,000181,013,000181,353,000170,981,000

Hid Other Operating Expenses

95,145,00075,134,00051,489,0008,671,000

Operating Income

562,921,000582,377,000545,055,000536,266,000

[-] Net Interest Income

- 480,000.00495,000.001,609,000.00

Hid Interest Expense

42,98743,26843,55337,606

Hid Interest Income

- 480,000.00495,000.00495,000.00

Hid Total Other Finance Cost

-42,987-43,268-43,553-1,151,606

Total Other Income Expense Net

-6,747,000-3,403,000-2,021,0003,951,000

Income Before Tax

556,174,000578,974,000543,034,000540,217,000

Tax Provision

160,730,000168,825,000155,718,000153,254,000

[-] Net Income Applicable To Common Shares

395,485,000410,190,000387,357,000386,963,000

Hid [-] Net Income

395,485,000410,190,000387,357,000386,963,000

HidHid [-] Net Income Including Non-Controlling Interests

395,444,000410,149,000387,316,000386,963,000

HidHidHid Net Income From Continuing Ops

- 111,860,000.00186,261,000.00277,467,000.00

HidHidHid Discontinued Operations

- - - -

HidHid Minority Interest Expense

-41,000-41,000-41,0000.0

Hid Preferred Stock And Other Adjustments

0.00.00.00.0

Diluted EPS

240.29249.22235.36235.14

Diluted Average Shares

1,645,6731,645,8021,646,2981,645,841

EBITDA

558,974,000581,773,000545,833,000543,023,000

EBIT

556,174,000578,973,000543,033,000540,223,000